Back to results
US 2008/0293797 A1Published application
Cycloalkane-Substituted Pyrazoline Derivatives, Their Preparation and Use as Medicaments
AssigneeLaboratorios Del Dr. Esteve, S.A.
InventorsAntonio Torrens Jover, Susana Yenes Minguez
Life of this patent
Estimating the term…
Abstract
The present invention relates to Cycloalkane-substituted pyrazoline compounds of formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.
Claims22
Cycloalkane-substituted pyrazoline compounds of general formula I,
- wherein
- Z is selected from C1-4-Alkyl, substituted or unsubstituted, branched or linear, saturated or unsaturated;
- X and Y independently represent phenyl, thienyl, naphtyl or pyridyl which groups may be substituted with 1, 2 or 3 substituents W, which can be the same or different, selected from the group
- branched or linear C1-3-alkyl or branched or linear C1-3-alkoxy, phenyl, hydroxy, chloro, bromo, fluoro, iodo, SH, trifluoromethyl, CHF2, CH2F, OCHF2, trifluoromethylthio, trifluoromethoxy, methylsulfonyl, carboxyl, trifluoromethylsulfonyl, cyano, carbamoyl, sulfamoyl and acetyl;
- O—P, with P denominating a prodrug group consisting of substituted or unsubstituted, branched or linear, saturated or unsaturated C8-20-alkyl or C(O)—C1-20-alkyl;
- substituted or unsubstituted aryl, alkyl-aryl, heterocyclyl or alkyl-heterocyclyl;
- substituted or unsubstituted C(O)-aryl, C(O)-alkyl-aryl, C(O)-heterocyclyl or C(O)-alkyl-heterocyclyl;
- R8 representing Cycloalkyl—especially a C7-8-Cycloalkyl—unsubstituted or at least monosubstituted with 1, 2 or 3 substituents S′, which can be the same or different, selected from the group:
- H, F, Cl, Br, I, OH, SH, C1-4alkyl, C1-4alkoxy, CF3, CHF2, CH2F, OCF3, a keto-group, NO2 or NH2;
- n being 0 or 1
- optionally in the form of its racemate, pure stereoisomers, especially enantiomers or diastereomers or in the form of mixtures of stereoisomers, especially enantiomers or diastereomers, in any suitable ratio;
- in the form shown or in form of the acid or base or in form of a salt, especially a physiologically acceptable salt, or in form of a solvate, especially a hydrate or in form of a corresponding N-oxide thereof.
9 more elements
13-16. (canceled)
25-28. (canceled)
Dependencies are inferred from the claim text.